Generic Treprostinil for PAH Now Offers Subcutaneous Administration
whitesession / Pixabay

Generic Treprostinil for PAH Now Offers Subcutaneous Administration

  In 2019, generic pharmaceuticals and biosimilars leader Sandoz launched intravenous treprostinil for patients with pulmonary arterial hypertension (PAH). But according to a new media release, generic treprostinil is now…

Continue Reading Generic Treprostinil for PAH Now Offers Subcutaneous Administration